The FDA approved the first new drug for Alzheimer’s disease in nearly 20 years Monday, even though the decision to greenlight Biogen’s new drug has been fraught with controversy.
WBZ-TV's Mallika Marshall has more.
The FDA approved the first new drug for Alzheimer’s disease in nearly 20 years Monday, even though the decision to greenlight Biogen’s new drug has been fraught with controversy.
WBZ-TV's Mallika Marshall has more.
It could be a game-changer for treating Alzheimer’s, but not all are convinced. Veuer’s Tony Spitz has the details.
The FDA on Monday approved an experimental drug that aims to slow the progression of Alzheimer's disease, despite the fact that a..